Weight loss as a predictor of mortality in patients with interstitial lung disease. Issue 3 (16th September 2018)

• Record Type: Journal Article
• Authors: Pugashetti, Janelle; Graham, Julia; Boctor, Noelle; Mendez, Cesar; Foster, Elena; Juarez, Maya; Harper, Richart; Morrissey, Brian; Kadoch, Michael; Oldham, Justin M.
• Is Part Of: European respiratory journal. Volume 52:Issue 3(2018)
• Publication Date: 2018-09-16
• Subjects: Respiratory organs -- Diseases -- Periodicals; Respiration -- Periodicals; 616.2
• DOI: 10.1183/13993003.01289-2018
• Languages: English
• ISSNs: 0903-1936

Abstract

The interstitial lung diseases (ILDs) are a diverse group of diffuse parenchymal lung disorders that commonly result in pulmonary fibrosis. ILDs are broadly classified according to known and unknown aetiologies. Connective tissue disease-associated ILD (CTD-ILD) and chronic hypersensitivity pneumonitis (CHP) are among the most common ILDs of known aetiology, while idiopathic pulmonary fibrosis (IPF) and unclassifiable ILD (U-ILD) are among the most common of unknown aetiology [1–4]. Weight loss in patients with ILD was associated with increased mortality risk in those with IPF and U-ILD http://ow.ly/Nk0D30l2Apm